International Journal of Cancer Management

Published by: Kowsar

The Dual Nature of Iron in Relation to Cancer: A Review

Sayed Hossein Davoodi 1 , 2 , Yasaman Jamshidi-Naeini 2 , Saeideh Esmaeili 3 , Sara Sohrabvandi 3 and Amir M. Mortazavian 3 , *
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Cancer Prevention: December 2016, 9 (6); e5494
  • Published Online: December 11, 2016
  • Article Type: Review Article
  • Received: January 27, 2016
  • Revised: June 22, 2016
  • Accepted: December 4, 2016
  • DOI: 10.17795/ijcp-5494

To Cite: Hossein Davoodi S, Jamshidi-Naeini Y, Esmaeili S, Sohrabvandi S, Mortazavian A M. The Dual Nature of Iron in Relation to Cancer: A Review, Int J Cancer Manag. 2016 ; 9(6):e5494. doi: 10.17795/ijcp-5494.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Carcinogenic Effects of Excess Iron
3. Therapeutic Effects of Excess Iron
4. Therapeutic Effects of Iron Defficiency
5. Carcinogenic Effects of Iron Deficiency
6. Conclusion
Acknowledgements
Footnotes
References
  • 1. Davoodi SH, Malek-Shahabi T, Malekshahi-Moghadam A, Shahbazi R, Esmaeili S. Obesity as an important risk factor for certain types of cancer. Iran J Cancer Prev. 2013; 6(4): 186-94[PubMed]
  • 2. Davoodi H, Esmaeili S, Mortazavian AM. Effects of milk and milk products consumption on cancer: A review. Compr Rev Food Sci Food Saf. 2013; 12(3): 249-64[DOI]
  • 3. Beliveau R, Gingras D. Role of nutrition in preventing cancer. Can Fam Physician. 2007; 53(11): 1905-11[PubMed]
  • 4. Kalinowski DS, Richardson DR. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol Rev. 2005; 57(4): 547-83[DOI][PubMed]
  • 5. Mascitelli L, Goldstein MR. Inhibition of iron absorption by polyphenols as an anti-cancer mechanism. QJM. 2011; 104(5): 459-61[DOI][PubMed]
  • 6. Gallagher ML. Intake: The nutrients and their metabolism; mahan lk, escott-stump s, raymond jl; krause's food and the nutrition care process. 2012;
  • 7. Ferritin blood test.
  • 8. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res. 2003; 533(1-2): 153-71[PubMed]
  • 9. Cherayil BJ. Iron and immunity: immunological consequences of iron deficiency and overload. Arch Immunol Ther Exp (Warsz). 2010; 58(6): 407-15[DOI][PubMed]
  • 10. Bird CL, Witte JS, Swendseid ME, Shikany JM, Hunt IF, Frankl HD, et al. Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol. 1996; 144(1): 34-41[PubMed]
  • 11. Huang X. Does iron have a role in breast cancer? Lancet Oncol. 2008; 9(8): 803-7[DOI][PubMed]
  • 12. Jian J, Pelle E, Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal. 2009; 11(12): 2939-43[DOI][PubMed]
  • 13. Geissler C, Singh M. Iron, meat and health. Nutrients. 2011; 3(3): 283-316[DOI][PubMed]
  • 14. Connor JR, Lee SY. Iron and Cancer. 2010; : 469-96[DOI]
  • 15. Kovacevic Z, Kalinowski DS, Lovejoy DB, Yu Y, Suryo Rahmanto Y, Sharpe PC, et al. The medicinal chemistry of novel iron chelators for the treatment of cancer. Curr Top Med Chem. 2011; 11(5): 483-99[PubMed]
  • 16. Foy SP, Labhasetwar V. Oh the irony: Iron as a cancer cause or cure? Biomaterials. 2011; 32(35): 9155-8[DOI][PubMed]
  • 17. Choi JY, Neuhouser ML, Barnett MJ, Hong CC, Kristal AR, Thornquist MD, et al. Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort. Carcinogenesis. 2008; 29(5): 964-70[DOI][PubMed]
  • 18. Alberts DS, Lluria-Prevatt M, Foreword MJA, Romagnolo DF. Bioactive compounds and cancer. 2010;
  • 19. Kabat GC, Rohan TE. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis. Cancer Causes Control. 2007; 18(10): 1047-53[DOI][PubMed]
  • 20. Toyokuni S. Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr. 2011; 48(1): 46-9[DOI][PubMed]
  • 21. Storz P. Reactive oxygen species in tumor progression. Front Biosci. 2005; 10: 1881-96[PubMed]
  • 22. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006; 160(1): 1-40[DOI][PubMed]
  • 23. Munoz M, Villar I, Garcia-Erce JA. An update on iron physiology. World J Gastroenterol. 2009; 15(37): 4617-26[PubMed]
  • 24. Cross AJ, Ferrucci LM, Risch A, Graubard BI, Ward MH, Park Y, et al. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res. 2010; 70(6): 2406-14[DOI][PubMed]
  • 25. Daniel CR, Cross AJ, Graubard BI, Hollenbeck AR, Park Y, Sinha R. Prospective investigation of poultry and fish intake in relation to cancer risk. Cancer Prev Res (Phila). 2011; 4(11): 1903-11[DOI][PubMed]
  • 26. Corpet DE. Red meat and colon cancer: should we become vegetarians, or can we make meat safer? Meat Sci. 2011; 89(3): 310-6[DOI][PubMed]
  • 27. Balder HF, Vogel J, Jansen MC, Weijenberg MP, van den Brandt PA, Westenbrink S, et al. Heme and chlorophyll intake and risk of colorectal cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev. 2006; 15(4): 717-25[DOI][PubMed]
  • 28. Luqman M, Javed MM, Daud S, Raheem N, Ahmad J, Khan AU. Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev. 2014; 15(7): 3035-9[PubMed]
  • 29. Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, et al. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr. 2009; 89(6): 1884-94[DOI][PubMed]
  • 30. Pierre F, Freeman A, Tache S, Van der Meer R, Corpet DE. Beef meat and blood sausage promote the formation of azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colons. J Nutr. 2004; 134(10): 2711-6[PubMed]
  • 31. Sesink AL, Termont DS, Kleibeuker JH, Van der Meer R. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res. 1999; 59(22): 5704-9[PubMed]
  • 32. Ilsley JN, Belinsky GS, Guda K, Zhang Q, Huang X, Blumberg JB, et al. Dietary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer. 2004; 49(2): 162-9[DOI][PubMed]
  • 33. Ferrucci LM, Sinha R, Ward MH, Graubard BI, Hollenbeck AR, Kilfoy BA, et al. Meat and components of meat and the risk of bladder cancer in the NIH-AARP Diet and Health Study. Cancer. 2010; 116(18): 4345-53[DOI][PubMed]
  • 34. Loh YH, Jakszyn P, Luben RN, Mulligan AA, Mitrou PN, Khaw KT. N-Nitroso compounds and cancer incidence: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Am J Clin Nutr. 2011; 93(5): 1053-61[DOI][PubMed]
  • 35. Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res. 2003; 63(10): 2358-60[PubMed]
  • 36. Kuhnle GGC, Bingham SA. Meats, Protein and Cancer. 2010; : 195-212[DOI]
  • 37. Lotrean LM, Ailoaiei R, Torres GM. Health risk behavior of Romanian adults having relatives with cancer. Asian Pac J Cancer Prev. 2013; 14(11): 6465-8[PubMed]
  • 38. Pierre F, Peiro G, Tache S, Cross AJ, Bingham SA, Gasc N, et al. New marker of colon cancer risk associated with heme intake: 1,4-dihydroxynonane mercapturic acid. Cancer Epidemiol Biomarkers Prev. 2006; 15(11): 2274-9[DOI][PubMed]
  • 39. Kabat GC, Cross AJ, Park Y, Schatzkin A, Hollenbeck AR, Rohan TE, et al. Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr. 2010; 92(6): 1478-83[DOI][PubMed]
  • 40. Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, et al. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer. 2009; 101(1): 178-84[DOI][PubMed]
  • 41. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2007; 16(6): 1306-8[DOI][PubMed]
  • 42. Kallianpur AR, Lee SA, Gao YT, Lu W, Zheng Y, Ruan ZX, et al. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat. 2008; 107(1): 123-32[DOI][PubMed]
  • 43. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study. Br J Cancer. 2008; 98(1): 194-8[DOI][PubMed]
  • 44. Genkinger JM, Friberg E, Goldbohm RA, Wolk A. Long-term dietary heme iron and red meat intake in relation to endometrial cancer risk. Am J Clin Nutr. 2012; 96(4): 848-54[DOI][PubMed]
  • 45. Kabat GC, Miller AB, Jain M, Rohan TE. A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Br J Cancer. 2007; 97(1): 118-22[DOI][PubMed]
  • 46. Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A, et al. Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol. 2009; 170(9): 1165-77[DOI][PubMed]
  • 47. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest. 2013; 123(1): 479-92[DOI][PubMed]
  • 48. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer. 2008; 60(2): 131-44[DOI][PubMed]
  • 49. Santarelli RL, Vendeuvre JL, Naud N, Tache S, Gueraud F, Viau M, et al. Meat processing and colon carcinogenesis: cooked, nitrite-treated, and oxidized high-heme cured meat promotes mucin-depleted foci in rats. Cancer Prev Res (Phila). 2010; 3(7): 852-64[DOI][PubMed]
  • 50. Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, et al. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res. 2005; 65(17): 8034-41[DOI][PubMed]
  • 51. Zheng W, Lee SA. Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer. 2009; 61(4): 437-46[DOI][PubMed]
  • 52. Alaejos MS, Afonso AM. Factors that affect the content of heterocyclic aromatic amines in foods. Compr Rev Food Sci Food Saf. 2011; 10(2): 52-108[DOI]
  • 53. Lakshmi VM, Hsu FF, Zenser TV. Nitric oxide-mediated nitrosation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline potentiated by hemin and myeloperoxidase. Chem Res Toxicol. 2005; 18(6): 1038-47[DOI][PubMed]
  • 54. Lakshmi VM, Clapper ML, Chang WC, Zenser TV. Hemin potentiates nitric oxide-mediated nitrosation of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to 2-nitrosoamino-3-methylimidazo[4,5-f]quinoline. Chem Res Toxicol. 2005; 18(3): 528-35[DOI][PubMed]
  • 55. Yuste J, Mor-Mur M, Capellas M, Guamis B, Pla R. Mechanically recovered poultry meat sausages manufactured with high hydrostatic pressure. Poult Sci. 1999; 78(6): 914-21[PubMed]
  • 56. Ma H, Ledward DA. High pressure processing of fresh meat--is it worth it? Meat Sci. 2013; 95(4): 897-903[DOI][PubMed]
  • 57. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager M, et al. Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila). 2011; 4(9): 1465-75[DOI][PubMed]
  • 58. Kesavan Y, Giovannucci E, Fuchs CS, Michaud DS. A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol. 2010; 171(2): 233-41[DOI][PubMed]
  • 59. Levi F, Pasche C, Lucchini F, La Vecchia C. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer. 2001; 91(2): 260-3[PubMed]
  • 60. Payandeh M, Khodarahmi R, Sadeghi M, Sadeghi E. Appearance of Acute Myelogenous Leukemia (AML) in a Patient with Breast Cancer after Adjuvant Chemotherapy: Case Report and Review of the Literature. Iran J Cancer Prev. 2015; 8(2): 125-8[PubMed]
  • 61. Abraham BK, Justenhoven C, Pesch B, Harth V, Weirich G, Baisch C, et al. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14(5): 1102-7[DOI][PubMed]
  • 62. Jian J, Yang Q, Dai J, Eckard J, Axelrod D, Smith J, et al. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med. 2011; 50(7): 841-7[DOI][PubMed]
  • 63. Bae YJ, Yeon JY, Sung CJ, Kim HS, Sung MK. Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients. J Clin Biochem Nutr. 2009; 45(3): 355-60[DOI][PubMed]
  • 64. Lee DH, Anderson KE, Harnark LJ, Jacobs DR. Dietary iron intake and breast cancer: The iowa women's heath study. Proc Am Assoc Cancer Res. 2004; 45(1): 535
  • 65. Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G. Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany. Nutr Cancer. 2003; 46(2): 131-7[DOI][PubMed]
  • 66. Huang X, Katz S. Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr. 2011; 94(2): 613-4[DOI][PubMed]
  • 67. Hong CC, Ambrosone CB, Ahn J, Choi JY, McCullough ML, Stevens VL, et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(9): 1784-94[DOI][PubMed]
  • 68. Kallianpur AR, Hall LD, Yadav M, Christman BW, Dittus RS, Haines JL, et al. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2004; 13(2): 205-12[PubMed]
  • 69. Beckman LE, Van Landeghem GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, et al. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis. 1999; 20(7): 1231-3[PubMed]
  • 70. Cujic, D. , Stefanoska, I. , Golubovic, S. . Serum ferritin in healthy women and breast cancer patients. J Med Biochem . 2011; 30(1): 33-7
  • 71. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr. 1999; 69(2): 250-5[PubMed]
  • 72. Keshtkar A, Semnani SH, Besharat S, Aboomardani M, Abdolahi N, Roshandel GH, et al. Colorectal cancer nutritional risk factors: A population based case-control study. Iran J Cancer Prev. 2012; 3(2): 93-7
  • 73. Butterworth JR. Another important function for an old friend! The role of iron in colorectal carcinogenesis. Gut. 2006; 55(10): 1384-6[DOI][PubMed]
  • 74. Chua AC, Klopcic B, Lawrance IC, Olynyk JK, Trinder D. Iron: an emerging factor in colorectal carcinogenesis. World J Gastroenterol. 2010; 16(6): 663-72[PubMed]
  • 75. Qiao L, Feng Y. Intakes of heme iron and zinc and colorectal cancer incidence: a meta-analysis of prospective studies. Cancer Causes Control. 2013; 24(6): 1175-83[DOI][PubMed]
  • 76. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Increases in the concentrations of available iron in response to dietary iron supplementation are associated with changes in crypt cell proliferation in rat large intestine. J Nutr. 1998; 128(2): 175-9[PubMed]
  • 77. Lund EK, Fairweather-Tait SJ, Wharf SG, Johnson IT. Chronic exposure to high levels of dietary iron fortification increases lipid peroxidation in the mucosa of the rat large intestine. J Nutr. 2001; 131(11): 2928-31[PubMed]
  • 78. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975; 15(4): 617-31[PubMed]
  • 79. Bastide NM, Pierre FH, Corpet DE. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila). 2011; 4(2): 177-84[DOI][PubMed]
  • 80. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, Sawada N, et al. Zinc and heme iron intakes and risk of colorectal cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr. 2012; 96(4): 864-73[DOI][PubMed]
  • 81. Zhang X, Giovannucci EL, Smith-Warner SA, Wu K, Fuchs CS, Pollak M, et al. A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and women. Cancer Causes Control. 2011; 22(12): 1627-37[DOI][PubMed]
  • 82. Ashmore JH, Lesko SM, Miller PE, Cross AJ, Muscat JE, Zhu J, et al. Association of dietary and supplemental iron and colorectal cancer in a population-based study. Eur J Cancer Prev. 2013; 22(6): 506-11[DOI][PubMed]
  • 83. Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1996; 5(7): 503-7[PubMed]
  • 84. Chan AT, Ma J, Tranah GJ, Giovannucci EL, Rifai N, Hunter DJ, et al. Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst. 2005; 97(12): 917-26[DOI][PubMed]
  • 85. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliovaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer. 1994; 56(3): 379-82[PubMed]
  • 86. Kuvibidila SR, Gauthier T, Rayford W. Serum ferritin levels and transferrin saturation in men with prostate cancer. J Natl Med Assoc. 2004; 96(5): 641-9[PubMed]
  • 87. Hercberg S, Estaquio C, Czernichow S, Mennen L, Noisette N, Bertrais S, et al. Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr. 2005; 135(11): 2664-8[PubMed]
  • 88. Nomura A, Chyou PH, Stemmermann GN. Association of serum ferritin levels with the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev. 1992; 1(7): 547-50[PubMed]
  • 89. Stevens RG, Morris JE, Cordis GA, Anderson LE, Rosenberg DW, Sasser LB. Oxidative damage in colon and mammary tissue of the HFE-knockout mouse. Free Radic Biol Med. 2003; 34(9): 1212-6[PubMed]
  • 90. Osborne NJ, Gurrin LC, Allen KJ, Constantine CC, Delatycki MB, McLaren CE, et al. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology. 2010; 51(4): 1311-8[DOI][PubMed]
  • 91. Nelson RL, Davis FG, Persky V, Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer. 1995; 76(5): 875-9[DOI]
  • 92. Ekblom K, Marklund SL, Palmqvist R, Van Guelpen B, Hallmans G, Weinehall L, et al. Iron biomarkers in plasma, HFE genotypes, and the risk for colorectal cancer in a prospective setting. Dis Colon Rectum. 2012; 55(3): 337-44[DOI][PubMed]
  • 93. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst. 1994; 86(6): 455-60[PubMed]
  • 94. Lee DH, Anderson KE, Harnack LJ, Folsom AR, Jacobs DJ. Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst. 2004; 96(5): 403-7[PubMed]
  • 95. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol. 1998; 35(1): 55-71[PubMed]
  • 96. Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab. 2013; 17(3): 329-41[DOI][PubMed]
  • 97. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia. 2007; 50(5): 949-56[DOI]
  • 98. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Negassa A, Kabat GC, Rohan TE, et al. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab. 2009; 11(5): 472-9[DOI][PubMed]
  • 99. Ben Q, Xu M, Ning X, Liu J, Hong S, Huang W, et al. Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer. 2011; 47(13): 1928-37[DOI][PubMed]
  • 100. Molina-Montes E, Wark PA, Sanchez MJ, Norat T, Jakszyn P, Lujan-Barroso L, et al. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer. 2012; 131(7)-47[DOI][PubMed]
  • 101. Montonen J, Boeing H, Steffen A, Lehmann R, Fritsche A, Joost HG, et al. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia. 2012; 55(10): 2613-21[DOI][PubMed]
  • 102. Lee DH, Folsom AR, Jacobs DJ. Dietary iron intake and Type 2 diabetes incidence in postmenopausal women: the Iowa Women's Health Study. Diabetologia. 2004; 47(2): 185-94[DOI][PubMed]
  • 103. Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr. 2004; 79(1): 70-5[PubMed]
  • 104. Rajpathak S, Ma J, Manson J, Willett WC, Hu FB. Iron intake and the risk of type 2 diabetes in women: a prospective cohort study. Diabetes Care. 2006; 29(6): 1370-6[DOI][PubMed]
  • 105. Olsen GW, Mandel JS, Gibson RW, Wattenberg LW, Schuman LM. Nutrients and pancreatic cancer: a population-based case-control study. Cancer Causes Control. 1991; 2(5): 291-7[PubMed]
  • 106. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas. Am J Epidemiol. 1991; 134(2): 167-79[PubMed]
  • 107. Ghadirian P, Simard A, Baillargeon J, Maisonneuve P, Boyle P. Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer. 1991; 47(1): 1-6[PubMed]
  • 108. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst. 1998; 90(22): 1710-9[PubMed]
  • 109. Lin Y, Tamakoshi A, Hayakawa T, Naruse S, Kitagawa M, Ohno Y. Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan. J Gastroenterol. 2005; 40(3): 297-301[DOI][PubMed]
  • 110. Bravi F, Polesel J, Bosetti C, Talamini R, Negri E, Dal Maso L, et al. Dietary intake of selected micronutrients and the risk of pancreatic cancer: an Italian case-control study. Ann Oncol. 2011; 22(1): 202-6[DOI][PubMed]
  • 111. Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol. 2003; 157(12): 1115-25[PubMed]
  • 112. Heinen MM, Verhage BA, Goldbohm RA, van den Brandt PA. Meat and fat intake and pancreatic cancer risk in the Netherlands Cohort Study. Int J Cancer. 2009; 125(5): 1118-26[DOI][PubMed]
  • 113. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993; 22(1): 30-7[PubMed]
  • 114. Dongiovanni P, Fracanzani AL, Cairo G, Megazzini CP, Gatti S, Rametta R, et al. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis. Am J Pathol. 2010; 176(2): 1006-17[DOI][PubMed]
  • 115. Evangelista AS, Nakhle MC, de Araujo TF, Abrantes-Lemos CP, Deguti MM, Carrilho FJ, et al. HFE genotyping in patients with elevated serum iron indices and liver diseases. Biomed Res Int. 2015; 2015: 164671[DOI][PubMed]
  • 116. Sebastiani G, Walker AP. HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol. 2007; 13(35): 4673-89[PubMed]
  • 117. Kew MC. Hepatic iron overload and hepatocellular carcinoma. Cancer Lett. 2009; 286(1): 38-43[DOI][PubMed]
  • 118. Marrogi AJ, Khan MA, van Gijssel HE, Welsh JA, Rahim H, Demetris AJ, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J Natl Cancer Inst. 2001; 93(21): 1652-5[PubMed]
  • 119. Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol. 1999; 31(3): 508-13[PubMed]
  • 120. Hann HW, Kim CY, London WT, Blumberg BS. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Int J Cancer. 1989; 43(3): 376-9[PubMed]
  • 121. Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, et al. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int. 2007; 27(10): 1394-401[DOI][PubMed]
  • 122. Gordeuk VR, McLaren CE, MacPhail AP, Deichsel G, Bothwell TH. Associations of iron overload in Africa with hepatocellular carcinoma and tuberculosis: Strachan's 1929 thesis revisited. Blood. 1996; 87(8): 3470-6[PubMed]
  • 123. Mandishona E, MacPhail AP, Gordeuk VR, Kedda MA, Paterson AC, Rouault TA, et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology. 1998; 27(6): 1563-6[DOI][PubMed]
  • 124. Moyo VM, Makunike R, Gangaidzo IT, Gordeuk VR, McLaren CE, Khumalo H, et al. African iron overload and hepatocellular carcinoma (HA-7-0-080). Eur J Haematol. 1998; 60(1): 28-34[PubMed]
  • 125. Gangaidzo IT, Gordeuk VR. Hepatocellular carcinoma and African iron overload. Gut. 1995; 37(5): 727-30[PubMed]
  • 126. Gordeuk V, Mukiibi J, Hasstedt SJ, Samowitz W, Edwards CQ, West G, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 1992; 326(2): 95-100[DOI][PubMed]
  • 127. Kato J, Kobune M, Kohgo Y, Sugawara N, Hisai H, Nakamura T, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest. 1996; 98(4): 923-9[DOI][PubMed]
  • 128. Weinberg ED. Iron loading and disease surveillance. Emerg Infect Dis. 1999; 5(3): 346-52[DOI][PubMed]
  • 129. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol. 2007; 22(7): 1104-11[DOI][PubMed]
  • 130. Khosravi P, Zahiri J, Gazestani VH, Mirkhalaf S, Akbarzadeh M, Sadeghi M, et al. Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer. Iran J Cancer Prev. 2014; 7(4): 204-11[PubMed]
  • 131. Bashir MN, Ahmad MR, Malik A. Risk factors of prostate cancer: a case-control study in Faisalabad, Pakistan. Asian Pac J Cancer Prev. 2014; 15(23): 10237-40[PubMed]
  • 132. Jakszyn PG, Allen NE, Lujan-Barroso L, Gonzalez CA, Key TJ, Fonseca-Nunes A, et al. Nitrosamines and heme iron and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2012; 21(3): 547-51[DOI][PubMed]
  • 133. Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, van Breemen R, et al. Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention. J Natl Cancer Inst. 2001; 93(24): 1872-9[PubMed]
  • 134. Tappel A. Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med Hypotheses. 2007; 68(3): 562-4[DOI][PubMed]
  • 135. Ornstein DL, Zacharski LR. Iron stimulates urokinase plasminogen activator expression and activates nf-kappa b in human prostate cancer cells. Nutrition Cancer. 2007; 58(1): 115-26[DOI]
  • 136. Ma RW, Chapman K. A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet. 2009; 22(3): 187-99[DOI][PubMed]
  • 137. Kolonel LN. Fat, meat, and prostate cancer. Epidemiol Rev. 2001; 23(1): 72-81[PubMed]
  • 138. Alexander DD, Mink PJ, Cushing CA, Sceurman B. A review and meta-analysis of prospective studies of red and processed meat intake and prostate cancer. Nutr J. 2010; 9: 50[DOI][PubMed]
  • 139. Nicastro HL, Dunn BK. Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT). Nutrients. 2013; 5(4): 1122-48[DOI][PubMed]
  • 140. Matos HR, Marques SA, Gomes OF, Silva AA, Heimann JC, Di Mascio P, et al. Lycopene and beta-carotene protect in vivo iron-induced oxidative stress damage in rat prostate. Braz J Med Biol Res. 2006; 39(2): 203-10[PubMed]
  • 141. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer. 1994; 56(3): 364-9[PubMed]
  • 142. Kuvibidila S, Gauthier T, Warrier RP, Rayford W. Increased levels of serum transferrin receptor and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med. 2004; 144(4): 176-82[DOI][PubMed]
  • 143. Tandon VR, Sharma S, Mahajan A, Bardi GH. Oxidative stress: a novel strategy in cancer treatment. . J K Sci. 2005; 7(1): 48
  • 144. Miguel M, Cordero MD. Oxidative therapy against cancer. 2012;
  • 145. Amirijavid S, Hashemi M. Detection of Anticancer and Apoptotic Effect of the Produced IgYs against the Three Extracellular Domain of Human DR5 Protein. Iran J Cancer Prev. 2015; 8(2): 109-15[PubMed]
  • 146. Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, et al. Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma. Cancer Lett. 2002; 182(1): 69-74[PubMed]
  • 147. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2): 97-110[DOI][PubMed]
  • 148. McCarty MF, Barroso-Aranda J, Contreras F. Oxidative stress therapy for solid tumors - a proposal. Med Hypotheses. 2010; 74(6): 1052-4[DOI][PubMed]
  • 149. Ferle-Vidovic A, Poljak-Blazi M, Rapic V, Skare D. Ferrocenes (F168, F169) and fero-sorbitol-citrate (FSC): potential anticancer drugs. Cancer Biother Radiopharm. 2000; 15(6): 617-24[PubMed]
  • 150. Kiessling MK, Klemke CD, Kaminski MM, Galani IE, Krammer PH, Gulow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 2009; 69(6): 2365-74[DOI][PubMed]
  • 151. Alarifi S, Ali D, Alkahtani S, Alhader MS. Iron oxide nanoparticles induce oxidative stress, DNA damage, and caspase activation in the human breast cancer cell line. Biol Trace Elem Res. 2014; 159(1-3): 416-24[DOI][PubMed]
  • 152. Gumienna-Kontecka E, Pyrkosz-Bulska M, Szebesczyk A, Ostrowska M. Iron chelating strategies in systemic metal overload, neurodegeneration and cancer. Curr Med Chem. 2014; 21(33): 3741-67[PubMed]
  • 153. Jiao Y, Wilkinson J, Di X, Wang W, Hatcher H, Kock ND, et al. Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. Blood. 2009; 113(2): 462-9[DOI][PubMed]
  • 154. Saletta F, Kovacevic Z, Richardson DR. Iron chelation: deciphering novel molecular targets for cancer therapy. The tip of the iceberg of a web of iron-regulated molecules. Future Med Chem. 2011; 3(16): 1983-6[DOI][PubMed]
  • 155. Jiao Y, Wilkinson J, Christine Pietsch E, Buss JL, Wang W, Planalp R, et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006; 40(7): 1152-60[DOI][PubMed]
  • 156. Bayet-Robert M, Kwiatkowski F, Leheurteur M, Gachon F, Planchat E, Abrial C, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther. 2010; 9(1): 8-14[PubMed]
  • 157. Tavakoli J, Miar S, Majid Zadehzare M, Akbari H. Evaluation of effectiveness of herbal medication in cancer care: a review study. Iran J Cancer Prev. 2012; 5(3): 144-56[PubMed]
  • 158. Minear S, O'Donnell AF, Ballew A, Giaever G, Nislow C, Stearns T, et al. Curcumin inhibits growth of Saccharomyces cerevisiae through iron chelation. Eukaryot Cell. 2011; 10(11): 1574-81[DOI][PubMed]
  • 159. Du XX, Xu HM, Jiang H, Song N, Wang J, Xie JX. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease. Neurosci Bull. 2012; 28(3): 253-8[DOI][PubMed]
  • 160. Hutchinson C, Bomford A, Geissler CA. The iron-chelating potential of silybin in patients with hereditary haemochromatosis. Eur J Clin Nutr. 2010; 64(10): 1239-41[DOI][PubMed]
  • 161. Kauntz H, Bousserouel S, Gosse F, Marescaux J, Raul F. Silibinin, a natural flavonoid, modulates the early expression of chemoprevention biomarkers in a preclinical model of colon carcinogenesis. Int J Oncol. 2012; 41(3): 849-54[DOI][PubMed]
  • 162. Raina K, Rajamanickam S, Singh RP, Deep G, Chittezhath M, Agarwal R. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model. Cancer Res. 2008; 68(16): 6822-30[DOI][PubMed]
  • 163. Bares JM, Berger J, Nelson JE, Messner DJ, Schildt S, Standish LJ, et al. Silybin treatment is associated with reduction in serum ferritin in patients with chronic hepatitis C. J Clin Gastroenterol. 2008; 42(8): 937-44[DOI][PubMed]
  • 164. Vaid M, Katiyar SK. Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review). Int J Oncol. 2010; 36(5): 1053-60[PubMed]
  • 165. Bhasin G, Kausar H, Sarwar Alam M, Athar M. Progressive iron overload enhances chemically mediated tumor promotion in murine skin. Arch Biochem Biophys. 2003; 409(2): 262-73[PubMed]
  • 166. Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, et al. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst. 2008; 100(14): 996-1002[DOI][PubMed]
  • 167. Merk K, Mattsson B, Mattsson A, Holm G, Gullbring B, Bjorkholm M. The incidence of cancer among blood donors. Int J Epidemiol. 1990; 19(3): 505-9[PubMed]
  • 168. Edgren G, Reilly M, Hjalgrim H, Tran TN, Rostgaard K, Adami J, et al. Donation frequency, iron loss, and risk of cancer among blood donors. J Natl Cancer Inst. 2008; 100(8): 572-9[DOI][PubMed]
  • 169. World Health Organization. . Micronutrient deficiencies. Iron deficiency anemia.
  • 170. Nutritional and safety assessments of foods and feeds nutritionally improved through biotechnology: An executive summary a task force report by the international life sciences institute, Washington, D.C. Compr Rev Food Sci Food Saf. 2004; 3(2): 35-104[DOI]
  • 171. Pra D, Rech Franke SI, Pegas Henriques JA, Fenech M. A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer. 2009; 61(4): 415-26[DOI][PubMed]
  • 172. Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr. 1987; 46(2): 329-34[PubMed]
  • 173. Lockwood JF, Sherman AR. Spleen natural killer cells from iron-deficient rat pups manifest an altered ability to be stimulated by interferon. J Nutr. 1988; 118(12): 1558-63[PubMed]
  • 174. Spear AT, Sherman AR. Iron deficiency alters DMBA-induced tumor burden and natural killer cell cytotoxicity in rats. J Nutr. 1992; 122(1): 46-55[PubMed]
  • 175. Kuvibidila SR, Velez M, Gardner R, Penugonda K, Chandra LC, Yu L. Iron deficiency reduces serum and in vitro secretion of interleukin-4 in mice independent of altered spleen cell proliferation. Nutr Res. 2012; 32(2): 107-15[DOI][PubMed]
  • 176. Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N. Natural killer cells: role in local tumor growth and metastasis. Biologics. 2012; 6: 73-82[DOI][PubMed]
  • 177. Bredenkamp JK, Castro DJ, Mickel RA. Importance of iron repletion in the management of Plummer-Vinson syndrome. Ann Otol Rhinol Laryngol. 1990; 99(1): 51-4[PubMed]
  • 178. Tabatabaei SA, Hashemi SM, Kelidari B. Transhiatal Esophagectomy without Mediastinal Manipulation for Lower Third Esophageal and Cardial Cancers: The First Experience of a New Technique. Iran J Cancer Prev. 2015; 8(2): 89-93[PubMed]
  • 179. Kim KH, Kim MC, Jung GJ. Gastric cancer occurring in a patient with Plummer-Vinson syndrome: a case report. World J Gastroenterol. 2005; 11(44): 7048-50[PubMed]
  • 180. Broitman SA, Velez H, Vitale JJ. A possible role of iron deficiency in gastric cancer in Colombia. Adv Exp Med Biol. 1981; 135: 155-81[PubMed]
  • 181. Zhang YW, Eom SY, Kim YD, Song YJ, Yun HY, Park JS, et al. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in Koreans. Int J Cancer. 2009; 125(1): 139-45[DOI][PubMed]
  • 182. Richie JJ, Kleinman W, Marina P, Abraham P, Wynder EL, Muscat JE. Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer. 2008; 60(4): 474-82[DOI][PubMed]
  • 183. Maxwell P, Salnikow K. HIF-1: an oxygen and metal responsive transcription factor. Cancer Biol Ther. 2004; 3(1): 29-35[PubMed]
  • 184. Liu LZ, Jing Y, Jiang LL, Jiang XE, Jiang Y, Rojanasakul Y, et al. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1alpha pathway. Biochem Biophys Res Commun. 2011; 413(2): 299-305[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments